Your browser doesn't support javascript.
loading
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial.
Basset-Séguin, N; Hauschild, A; Kunstfeld, R; Grob, J; Dréno, B; Mortier, L; Ascierto, P A; Licitra, L; Dutriaux, C; Thomas, L; Meyer, N; Guillot, B; Dummer, R; Arenberger, P; Fife, K; Raimundo, A; Dika, E; Dimier, N; Fittipaldo, A; Xynos, I; Hansson, J.
Affiliation
  • Basset-Séguin N; Department of Dermatology, Hôpital Saint Louis, 1 Avenue Claude Vellefaux, 75475, Paris, France. Electronic address: nicole.basset-seguin@aphp.fr.
  • Hauschild A; Department of Dermatology, University of Kiel, Rosalind-Franklin-Str 7, D-24105, Kiel, Germany. Electronic address: ahauschild@dermatology.uni-kiel.de.
  • Kunstfeld R; University Dermatology Clinic, Medical University of Vienna, Währinger Gürtel 18-20, A-1090, Vienna, Austria. Electronic address: rainer.kunstfeld@meduniwien.ac.at.
  • Grob J; Dermatology and Oncology Service, Aix Marseille University and Timone Hospital, 264 Rue St. Pierre, 13385, Cedex 05 Marseille, France. Electronic address: jean-jacques.grob@mail.ap-hm.fr.
  • Dréno B; Department of Dermato Oncology, University Hospital Nantes, Hotel Dieu, Place Alexis Ricordeau, 44093, Cedex 01 Nantes, France. Electronic address: brigitte.dreno@wanadoo.fr.
  • Mortier L; Dermatology Service, University of Lille 2, Lille Regional University Hospital, Hôpital Huriez, 2 Avenue Oscar Lambret, 59037, Lille, France. Electronic address: laurent.mortier@chru-lille.fr.
  • Ascierto PA; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Via Mariano Semmola, 80131, Naples, Italy. Electronic address: paolo.ascierto@gmail.com.
  • Licitra L; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, and University of Milan, Via Giacomo Venezian 1, 20133, Italy. Electronic address: lisa.licitra@istitutotumori.mi.it.
  • Dutriaux C; Dermatology Service, University Hospital of Bordeaux, 1 Rue Jean Burguet, 33075, Bordeaux, France. Electronic address: caroline.dutriaux@chu-bordeaux.fr.
  • Thomas L; Dermatology Service, Centre Hospitalier Universitaire de Lyon, Centre Hospitalier Lyon Sud, 69495, Pierre Bénite, Lyon, France. Electronic address: luc.thomas@chu-lyon.fr.
  • Meyer N; Skin Cancer Unit, Paul Sabatier University and Toulouse University Cancer Institute, 24 Chemin de Pouvourville TSA30030, 31059, Toulouse, France. Electronic address: meyer.n@chu-toulouse.fr.
  • Guillot B; Dermatology Department, University Hospital of Montpellier, 80 Avenue Augustin Fliche, 34090, Montpellier, France. Electronic address: b-quillot@chu-montpellier.fr.
  • Dummer R; Dermatology Department, University Hospital Zurich, Gloriastr. 31, 8091, Zurich, Switzerland. Electronic address: Reinhard.Dummer@usz.ch.
  • Arenberger P; Dermatology Department, Charles University Third Faculty of Medicine, Srobárova 1150/50, 100 34, Praha 10, Prague, Czech Republic. Electronic address: pa@avemedica.cz.
  • Fife K; Oncology Centre, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2OQ, UK. Electronic address: kate.fife@addenbrookes.nhs.uk.
  • Raimundo A; Oncology Department, Instituto Portugues de Oncologia, R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal. Electronic address: anaraimundo@hotmail.com.
  • Dika E; Dermatology, Department of Diagnostic, Experimental and Specialty Medicine, University of Bologna, Via Massarenti 1, 40138, Bologna, Italy. Electronic address: emi.dika3@unibo.it.
  • Dimier N; Roche Products Ltd., 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW, UK. Electronic address: natalie.dimier@roche.com.
  • Fittipaldo A; Roche Products Ltd., 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW, UK. Electronic address: alberto.fittipaldo@roche.com.
  • Xynos I; Roche Products Ltd., 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW, UK. Electronic address: xynosid@gmail.com.
  • Hansson J; Department of Oncology-Pathology, Karolinska University Hospital, Hospital Solma, 171 76, Stockholm, Sweden. Electronic address: Johan.Hansson@ki.se.
Eur J Cancer ; 86: 334-348, 2017 11.
Article in En | MEDLINE | ID: mdl-29073584
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Carcinoma, Basal Cell / Basal Cell Nevus Syndrome / Anilides / Antineoplastic Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2017 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Carcinoma, Basal Cell / Basal Cell Nevus Syndrome / Anilides / Antineoplastic Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2017 Document type: Article Country of publication: